Author

Paola Camargo-Mamani

Institution: Faes Farma (Spain)

Observed institutions: Hospital Universitario de La Princesa, Faes Farma (Spain), Instituto de Investigación Sanitaria del Hospital Universitario de La Princesa, Universidad Autónoma de Madrid

ORCID: 0009-0000-4694-2923

Observed ORCID: 0009-0000-4694-2923

OpenAlex ID: A5088849997

First-in-human phase I clinical trial of a TLR4-binding DNA aptamer, ApTOLL: Safety and pharmacokinetics in healthy volunteers

2022 · Macarena Hernández-Jiménez, Samuel Martín-Vílchez, et al. · Molecular Therapy — Nucleic Acids · 59

Identification of Transporter Polymorphisms Influencing Metformin Pharmacokinetics in Healthy Volunteers

2023 · Miriam Saiz-Rodríguez, Dolores Ochoa, et al. · Journal of Personalized Medicine · 18

Bioavailability of Oniria®, a Melatonin Prolonged-Release Formulation, Versus Immediate-Release Melatonin in Healthy Volunteers

2022 · Manuel Román Martinez, Eva García Aguilar, et al. · Drugs in R&D · 12

Safety, Pharmacokinetics, and Bioequivalence Characterization of Two Different Strengths of Mesalazine Gastro-Resistant Tablets

2025 · Dolores Ochoa Mazarro, Manuel Román Martínez, et al. · Pharmaceuticals · 3

Bioequivalence Study of Two Oral Methocarbamol Formulations in Healthy Subjects Under Fasting Conditions: A Randomized, Open-Label, Crossover Clinical Trial

2025 · Ana Ascaso-del-Rio, Paola Camargo-Mamani, et al. · Pharmaceuticals · 1

Works count: 5

Citation count: 93

H-index: 3

I10-index: 3